{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-154347","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.198011+00:00","generated_at":"2026-06-01T06:35:25.236218+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Royalty Pharma prices $1.5B senior notes offering across three tranches","bullets":["Issued $500M 5.150% Senior Notes due 2029, $500M 5.400% due 2034, and $500M 5.900% due 2054.","Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd.","Offering expected to close on June 10, 2024, subject to customary conditions.","Underwriting agreement with BofA, Citigroup, J.P. Morgan, Morgan Stanley, and TD Securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-154347","json":"https://secwatch.observer/filing/0001193125-24-154347.json","markdown":"https://secwatch.observer/filing/0001193125-24-154347.md","text":"https://secwatch.observer/filing/0001193125-24-154347.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312524154347/0001193125-24-154347-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312524154347/d821949d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:35:25.236218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}